A detailed history of Xtx Topco LTD transactions in Glaukos Corp stock. As of the latest transaction made, Xtx Topco LTD holds 3,100 shares of GKOS stock, worth $449,933. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,100
Holding current value
$449,933
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $352,222 - $419,708
3,100 New
3,100 $403,000
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $153,564 - $193,623
2,010 Added 44.36%
6,541 $616,000
Q4 2023

Feb 13, 2024

BUY
$59.53 - $85.11 $269,730 - $385,633
4,531 New
4,531 $360,000
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $233,782 - $415,169
-4,929 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$73.06 - $97.7 $360,112 - $481,563
4,929 New
4,929 $418,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.91B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.